A synthetic heptapeptide derived from ACTH(4-10), researched as a nootropic and neuroprotective agent; approved in Russia for stroke recovery and cognitive disorders.
An ACTH(4-10) analog without steroidogenic activity that rapidly upregulates BDNF and its TrkB receptor, plus NGF and VEGF, in the hippocampus and cortex, while modulating serotonergic/dopaminergic signalling — promoting neuroplasticity and neuroprotection.
Bars reflect the strength & volume of research evidence for each use — not a guarantee of results.
No reviews yet. If you've used Semax, be the first to share what it helped with and any side effects.
⚠️ Educational research information only — not medical advice. Many peptides are sold strictly for laboratory research and are not approved treatments. The evidence scores reflect research interest and strength, not efficacy or safety for any individual. Always consult a qualified professional.